Deerfield Management Company, L.P. (Series C) Guardant Health, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $11.6 Million - $15.9 Million	-538,200 Reduced 40.47%	791,735 $21.4 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $1.96 Million - $3.04 Million	75,936 Added 6.06%	1,329,935 $39.4 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $9.95 Million - $18.1 Million	475,000 Added 60.98%	1,253,999 $44.9 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $17.9 Million - $26.3 Million	778,999 New	778,999 $18.3 Million
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $7.5 Million - $10.4 Million	-126,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $7.89 Million - $13.9 Million	126,000 New	126,000 $8.04 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$430 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$413 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$372 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$254 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$220 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account